Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 32.19%115.83M | 43.89%104.82M | 4.61%70.24M | 13.52%324.04M | 17.32%96.42M | 87.63M | 72.85M | 67.15M | -21.30%285.44M | 82.19M |
| Cost of revenue | 33.88%104.05M | 42.57%91.78M | 7.92%61.92M | 19.58%288.67M | 20.29%87.57M | 77.72M | 64.38M | 57.38M | -26.30%241.41M | 72.8M |
| Gross profit | 18.92%11.78M | 53.93%13.04M | -14.83%8.32M | -19.68%35.37M | -5.72%8.85M | 9.91M | 8.47M | 9.77M | 25.34%44.03M | 9.39M |
| Operating expense | 1.54%3.03M | 232.66%4.76M | -29.31%3.2M | 0.37%11.01M | -7.15%3.53M | 2.99M | 1.43M | 4.52M | 61.28%10.97M | 3.81M |
| Selling and administrative expenses | 1.54%3.03M | 232.66%4.76M | -29.31%3.2M | -3.46%10.59M | -7.15%3.53M | --2.99M | --1.43M | --4.52M | 312.99%10.97M | --3.81M |
| -Selling and marketing expense | -24.19%1.13M | -57.47%592K | -5.36%1.06M | -7.00%3.25M | -29.07%876K | --1.48M | --1.39M | --1.12M | 160.26%3.5M | --1.24M |
| -General and administrative expense | 26.96%1.91M | 10,860.53%4.17M | -37.19%2.14M | -1.80%7.34M | 3.39%2.66M | --1.5M | --38K | --3.4M | 469.09%7.48M | --2.57M |
| Other operating expenses | ---- | ---- | ---- | --420.23K | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 26.42%8.75M | 17.62%8.28M | -2.36%5.12M | -26.33%24.35M | -4.74%5.32M | 6.92M | 7.04M | 5.25M | 16.71%33.06M | 5.59M |
| Net non-operating interest income (expenses) | -52.87%-1.3M | -81.17%-1.09M | -3.02%-1.03M | 63.78%-1.19M | 2.52%-930K | -853K | -600K | -995K | 19.35%-3.28M | -954K |
| Non-operating interest income | ---- | ---- | ---- | 133.02%2.19M | ---- | ---- | ---- | ---- | 170.98%940.29K | ---- |
| Non-operating interest expense | 52.87%1.3M | 81.17%1.09M | 3.02%1.03M | -19.90%3.38M | -2.52%930K | --853K | --600K | --995K | 1.13%4.22M | --954K |
| Net investment income | -60.70%276.65K | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 70.44%1.66M | -58.48%964K | 17.08%1M | 68.54%4.56M | 62.05%2.43M | 971K | 2.32M | 855K | 17.40%2.71M | 1.5M |
| Income before tax | 29.28%9.1M | -6.91%8.16M | -0.16%5.1M | -15.36%27.73M | 11.27%6.83M | 7.04M | 8.76M | 5.11M | 25.16%32.77M | 6.13M |
| Income tax | -19.20%867K | 2,018.97%1.23M | 371.43%561K | -93.20%629.46K | -130.50%-621K | 1.07M | 58K | 119K | 39.79%9.26M | 2.04M |
| Net income | 38.01%8.23M | -20.41%6.93M | -9.02%4.54M | 15.30%27.1M | 81.70%7.45M | 5.97M | 8.7M | 4.99M | 20.20%23.51M | 4.1M |
| Net income continuous operations | 38.01%8.23M | -20.41%6.93M | -9.02%4.54M | 15.30%27.1M | 81.70%7.45M | --5.97M | --8.7M | --4.99M | 20.20%23.51M | --4.1M |
| Noncontrolling interests | -354K | 7K | 70K | 93.07K | 93K | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 43.94%8.59M | -20.49%6.92M | -10.43%4.47M | 14.91%27.01M | 79.43%7.35M | 5.97M | 8.7M | 4.99M | 20.20%23.51M | 4.1M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 43.94%8.59M | -20.49%6.92M | -10.43%4.47M | 14.91%27.01M | 79.43%7.35M | 5.97M | 8.7M | 4.99M | 20.20%23.51M | 4.1M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 42.37%0.0084 | -21.84%0.0068 | -10.20%0.0044 | 16.29%0.0268 | 81.68%0.0073 | 0.0059 | 0.0087 | 0.0049 | 20.20%0.023 | 0.004 |
| Diluted earnings per share | 42.37%0.0084 | -21.84%0.0068 | -10.20%0.0044 | 16.29%0.0268 | 81.68%0.0073 | 0.0059 | 0.0087 | 0.0049 | 20.20%0.023 | 0.004 |
| Dividend per share | 76.92%0.0069 | 0 | 0 | 0.0127 | 0.0018 | 0.0039 | 0.007 | |||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.